Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q2

7776.TEDINET S100OZ8N
Period2022-01-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 28
MetricValuePeriodScopeSource row
Revenue¥75m2022-01-01 → 2022-06-30StandaloneNet sales
Revenue¥162m2021-01-01 → 2021-12-31StandaloneNet sales (5-year summary)
Operating income−¥349m2022-01-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥353m2022-01-01 → 2022-06-30StandaloneOrdinary income
Ordinary income−¥866m2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Profit before tax−¥355m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥357m2022-01-01 → 2022-06-30StandaloneProfit loss
Net income−¥913m2021-01-01 → 2021-12-31StandaloneNet income loss (5-year summary)
Total assets¥1.7bnat 2022-06-30StandaloneAssets
Total assets¥1.4bnat 2021-12-31StandaloneAssets
Total liabilities¥396mat 2022-06-30StandaloneLiabilities
Total liabilities¥364mat 2021-12-31StandaloneLiabilities
Net assets / equity¥1.3bnat 2022-06-30StandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31StandaloneNet assets
Cash and deposits¥1.2bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥847mat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥1.2bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥847mat 2021-12-31StandaloneCash and cash equivalents
Operating cash flow−¥269m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥15m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥606m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-18.542022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-7.752022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.082021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio75.1%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.4%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued22,159,419at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued17,759,419at 2021-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥100m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-06-30¥4m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-06-30¥4m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-06-30−¥208m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2022-01-01 → 2022-06-30¥70m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2022-01-01 → 2022-06-30¥70m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2022-01-01 → 2022-06-30−¥41m
—segment totalrevenue2022-01-01 → 2022-06-30¥75m
—segment totalrevenue external2022-01-01 → 2022-06-30¥75m
—segment totalsegment profit2022-01-01 → 2022-06-30−¥248m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 331
ItemContextValueUnit
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember400671000JPY
Noncurrent assetsCurrentQuarterInstant_NonConsolidatedMember397348000JPY
AssetsPrior1YearInstant_NonConsolidatedMember1408209000JPY
AssetsCurrentQuarterInstant_NonConsolidatedMember1695426000JPY
Accounts payable tradePrior1YearInstant_NonConsolidatedMember5023000JPY
Accounts payable tradeCurrentQuarterInstant_NonConsolidatedMember10343000JPY
Current portion of long term loans payablePrior1YearInstant_NonConsolidatedMember1250000JPY
Current portion of long term loans payableCurrentQuarterInstant_NonConsolidatedMember5625000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember4486000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember3976000JPY
Other clPrior1YearInstant_NonConsolidatedMember160524000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember187947000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember171284000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember207892000JPY
Long term loans payablePrior1YearInstant_NonConsolidatedMember158750000JPY
Long term loans payableCurrentQuarterInstant_NonConsolidatedMember154375000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember33546000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember33592000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember192296000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember187967000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember363581000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember395859000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember4548657000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember1326051000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember1770454000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember305632000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-5298692000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-357125000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-227000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-227000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1020191000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1274331000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember-321000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember-321000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember24757000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember25556000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1044627000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1299566000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1408209000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember1695426000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember74612000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember38570000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember36041000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember200501000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember184384000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember384886000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-348844000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember5000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2021-12-31pass rounding
balance sheet identitynon_consolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass